1. Home
  2. MC vs LGND Comparison

MC vs LGND Comparison

Compare MC & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Moelis & Company

MC

Moelis & Company

HOLD

Current Price

$54.28

Market Cap

4.5B

Sector

Finance

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$197.88

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MC
LGND
Founded
2007
1987
Country
United States
United States
Employees
N/A
68
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
MC
LGND
Price
$54.28
$197.88
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$76.88
$245.86
AVG Volume (30 Days)
1.4M
183.6K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
4.69%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
N/A
N/A
Revenue This Year
$20.91
$1.50
Revenue Next Year
$16.19
$18.28
P/E Ratio
$73.92
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$47.00
$93.58
52 Week High
$78.22
$227.92

Technical Indicators

Market Signals
Indicator
MC
LGND
Relative Strength Index (RSI) 37.92 44.28
Support Level $51.06 $179.55
Resistance Level $73.46 $207.72
Average True Range (ATR) 1.84 10.02
MACD 0.68 -1.59
Stochastic Oscillator 56.28 3.39

Price Performance

Historical Comparison
MC
LGND

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: